Garofalo Health Care S.p.A. (BIT:GHC)
Italy
· Delayed Price · Currency is EUR 5.06
+0.04 (0.80%)
At close: Apr 28, 2026
Garofalo Health Care Income Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Operating Revenue | 478.83 | 462.18 | 360.98 | 314.76 | 277.87 | Upgrade
|
| Other Revenue | 6.29 | 5.59 | 5.16 | 5.28 | 5.06 | Upgrade
|
| Revenue | 485.12 | 467.77 | 366.14 | 320.04 | 282.93 | Upgrade
|
| Revenue Growth (YoY) | 3.71% | 27.76% | 14.40% | 13.12% | 35.80% | Upgrade
|
| Cost of Revenue | 381.23 | 367.94 | 286.15 | 251.39 | 222.42 | Upgrade
|
| Gross Profit | 103.89 | 99.83 | 79.98 | 68.65 | 60.51 | Upgrade
|
| Selling, General & Admin | 0.98 | 1.01 | 0.89 | 0.83 | 0.67 | Upgrade
|
| Other Operating Expenses | 24.11 | 22.84 | 14.47 | 13.74 | 11.74 | Upgrade
|
| Operating Expenses | 52.99 | 49.18 | 36.8 | 32.93 | 27.93 | Upgrade
|
| Operating Income | 50.9 | 50.65 | 43.18 | 35.72 | 32.58 | Upgrade
|
| Interest Expense | -10.84 | -13.92 | -10.29 | -4.2 | -4.21 | Upgrade
|
| Interest & Investment Income | 0.48 | 1.07 | 0.28 | 0.02 | 0 | Upgrade
|
| Earnings From Equity Investments | 0.08 | 0.12 | 0.17 | 0.13 | 0.21 | Upgrade
|
| Other Non Operating Income (Expenses) | -0.91 | -0.71 | -0.46 | -0.24 | -0.25 | Upgrade
|
| EBT Excluding Unusual Items | 39.71 | 37.21 | 32.88 | 31.43 | 28.34 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | -0.02 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 0.22 | 0.61 | 0.08 | 0.14 | 0.06 | Upgrade
|
| Asset Writedown | -0.09 | -1.76 | -1.67 | -0.6 | -0.19 | Upgrade
|
| Legal Settlements | -5.98 | -5.4 | -2.39 | -3.78 | -2.73 | Upgrade
|
| Pretax Income | 33.96 | 30.69 | 28.93 | 27.37 | 25.48 | Upgrade
|
| Income Tax Expense | 10.39 | 8.84 | 8.06 | 5.94 | 6.63 | Upgrade
|
| Earnings From Continuing Operations | 23.57 | 21.85 | 20.87 | 21.43 | 18.84 | Upgrade
|
| Minority Interest in Earnings | -0.16 | -0.15 | -0.07 | -0.01 | -0.01 | Upgrade
|
| Net Income | 23.41 | 21.7 | 20.8 | 21.43 | 18.83 | Upgrade
|
| Net Income to Common | 23.41 | 21.7 | 20.8 | 21.43 | 18.83 | Upgrade
|
| Net Income Growth | 7.87% | 4.34% | -2.93% | 13.76% | 59.87% | Upgrade
|
| Shares Outstanding (Basic) | 89 | 88 | 89 | 89 | 89 | Upgrade
|
| Shares Outstanding (Diluted) | 90 | 90 | 89 | 89 | 89 | Upgrade
|
| Shares Change (YoY) | -0.77% | 2.11% | -0.40% | -0.37% | 9.34% | Upgrade
|
| EPS (Basic) | 0.26 | 0.25 | 0.23 | 0.24 | 0.21 | Upgrade
|
| EPS (Diluted) | 0.26 | 0.24 | 0.18 | 0.24 | 0.21 | Upgrade
|
| EPS Growth | 8.33% | 33.33% | -25.00% | 14.29% | 50.00% | Upgrade
|
| Free Cash Flow | 18.12 | 16.7 | 34.57 | 30.04 | 13.12 | Upgrade
|
| Free Cash Flow Per Share | 0.20 | 0.18 | 0.39 | 0.34 | 0.15 | Upgrade
|
| Dividend Per Share | 0.093 | 0.086 | - | - | - | Upgrade
|
| Dividend Growth | 8.14% | - | - | - | - | Upgrade
|
| Gross Margin | 21.42% | 21.34% | 21.84% | 21.45% | 21.39% | Upgrade
|
| Operating Margin | 10.49% | 10.83% | 11.79% | 11.16% | 11.52% | Upgrade
|
| Profit Margin | 4.83% | 4.64% | 5.68% | 6.69% | 6.66% | Upgrade
|
| Free Cash Flow Margin | 3.74% | 3.57% | 9.44% | 9.38% | 4.64% | Upgrade
|
| EBITDA | 74.19 | 75.98 | 64.62 | 54.09 | 48.1 | Upgrade
|
| EBITDA Margin | 15.29% | 16.24% | 17.65% | 16.90% | 17.00% | Upgrade
|
| D&A For EBITDA | 23.29 | 25.33 | 21.44 | 18.36 | 15.52 | Upgrade
|
| EBIT | 50.9 | 50.65 | 43.18 | 35.72 | 32.58 | Upgrade
|
| EBIT Margin | 10.49% | 10.83% | 11.79% | 11.16% | 11.52% | Upgrade
|
| Effective Tax Rate | 30.61% | 28.80% | 27.85% | 21.69% | 26.04% | Upgrade
|
| Revenue as Reported | 487.08 | 470.71 | 368.7 | 322.58 | 283.67 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.